Electrocardiogram (ECG) Telemetry Devices Market Report 2025

This electrocardiogram (ECG) telemetry devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The electrocardiogram (ECG) telemetry devices market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.5 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the increasing geriatric population, increasing cardiovascular diseases, increasing the number of home care monitoring devices, adoption of sedentary lifestyle, and growing life-threatening illnesses.

The electrocardiogram (ECG) telemetry devices market size is expected to see strong growth in the next few years. It will grow to $6.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the increasing prevalence of obesity, high consumption of alcohol and cigarette, growing awareness about cardiovascular health, prevalence of arrhythmia, and rising stress levels among individuals. Major trends in the forecast period include technological advancements, automated electrocardiogram (ECG) reading technology, integrating data analytics, sensor technology, internet of things (IoT), and mobile computing technology.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the electrocardiogram (ECG) telemetry devices market. Cardiovascular diseases (CVDs), which include conditions such as coronary artery disease, heart failure, and stroke, are increasingly common due to factors such as unhealthy diets, physical inactivity, tobacco use, excessive alcohol consumption, air pollution, and socioeconomic issues such as poverty and stress. ECG telemetry devices enhance cardiovascular care by providing continuous, real-time monitoring, supporting remote and home-based care, improving the functionality of implantable devices, aiding in accurate diagnosis and personalized treatment, and facilitating rapid emergency responses. For example, in January 2024, the American Heart Association reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, a 4% rise from 224.4 per 100,000 in 2023. Thus, the growing burden of cardiovascular diseases is fueling the demand for ECG telemetry devices.

Leading companies in the electrocardiogram (ECG) telemetry devices market are focused on developing advanced technologies, such as innovative cardiac monitoring devices that offer enhanced accuracy, real-time data transmission, and integration with mobile health platforms. These advancements enable improved remote patient management and early detection of cardiovascular events. A disruptive cardiac monitoring device represents a significant leap in technology by providing long-term, continuous heart rhythm monitoring and early detection of cardiac abnormalities, which facilitates timely diagnosis and treatment of cardiovascular diseases. For example, in March 2022, Biotricity, a US-based company known for its innovative remote monitoring devices and healthcare applications, introduced Biotres, a disruptive cardiac monitoring device. Biotres delivers continuous, three-channel ECG data to improve the detection of cardiac arrhythmias. Designed for extended wear, the device provides up to 30 days of monitoring with automated data offloading and wireless connectivity, reducing diagnostic turnaround times compared to traditional Holter monitors. Its user-friendly design and modular capabilities make Biotres a groundbreaking solution in the remote patient monitoring market, addressing the increasing need for efficient cardiac care.

In February 2022, Siigo, a software company based in the United States, acquired Aspel for an undisclosed amount. This acquisition is intended to improve Siigo's service offerings for small and medium-sized enterprises (SMEs) throughout Latin America. Aspel, based in Mexico, specializes in financial and accounting administrative software and also manufactures medical devices, including electrocardiogram (ECG) telemetry devices.

Major companies operating in the electrocardiogram (ECG) telemetry devices market are Johnson & Johnson, Medtronic PLC, Koninklijke Philips N.V., GE Healthcare Company, ZOLL Medical Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Hill-Rom Services Inc., BIOTRONIK, Nihon Kohden Corporation, iRhythm Technologies Inc., Schiller AG, CardioNet Inc., Preventice Solutions Inc., AliveCor Inc., Mortara Instrument Inc., Medicalgorithmics SA, Custo med GmbH, ScottCare Cardiovascular Solutions, Aerotel Medical Systems Ltd., Compumed Inc.

North America was the largest region in the electrocardiogram (ECG) telemetry devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiogram (ECG) telemetry devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrocardiogram (ECG) telemetry devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Electrocardiogram (ECG) telemetry devices are medical tools used to remotely monitor and record the electrical activity of a patient's heart over time. These devices are essential for diagnosing and managing various heart conditions, including arrhythmias, heart attacks, and other cardiovascular disorders. They play a crucial role in both inpatient and outpatient care, offering valuable information that can lead to early detection and timely intervention for heart-related issues.

The main product types of ECG telemetry devices include event monitoring and mobile cardiac telemetry devices, implantable loop recorders, and other variants. Event monitoring and mobile cardiac telemetry devices are designed to capture the heart's electrical activity over specific periods, particularly during symptoms such as palpitations or dizziness. These devices are utilized for monitoring conditions such as arrhythmias, myocardial ischemia and infarction, and pacemaker function, and are used by various end-users, including hospitals and home healthcare providers.

The electrocardiogram (ECG) telemetry devices market research report is one of a series of new reports that provides electrocardiogram (ECG) telemetry devices market statistics, including electrocardiogram (ECG) telemetry devices industry global market size, regional shares, competitors with an electrocardiogram (ECG) telemetry devices market share, detailed electrocardiogram (ECG) telemetry devices market segments, market trends, and opportunities, and any further data you may need to thrive in the electrocardiogram (ECG) telemetry devices industry. This electrocardiogram (ECG) telemetry devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electrocardiogram (ECG) telemetry devices market consists of sales of ECG devices, stress ECG devices, holter monitors, event monitoring systems, and ECG management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.